The Causal Relationship Between Type 2 Diabetes Mellitus and Isolated REM Sleep Behavior Disorder: Results from Multivariable and Network Mendelian Randomization Analysis

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Dec 10

PMID 39655344

Authors

Ru-Yu Zhang

Jin-Yu Li

Yu-Ning Liu

Zi-Xuan Zhang

Jie Zhao

Fu-Jia Li

Affiliations

Soon will be listed here.

Abstract

Objectives: To investigate the causal relationship between type 2 diabetes mellitus (T2DM, exposure) and isolated REM sleep behavior disorder (iRBD, outcome).

Methods: Genome-wide association study (GWAS) data for iRBD comprised 9,447 samples, including 1,061 iRBD cases from the International RBD Study Group. Initially, we performed linkage disequilibrium score regression (LDSC) to explore the genetic correlation between T2DM and iRBD. Then the two-sample univariate MR (UVMR) analysis was conducted to examine the effects of T2DM and blood sugar metabolism-related factors on iRBD. Subsequently, we applied multivariable MR (MVMR) methods to further adjust for confounders. Lastly, we executed a network MR analysis, with cytokines and immune cell characteristics as potential mediators, aiming to investigate indirect effect of T2DM on iRBD.

Results: Results from LDSC suggest a genetic correlation between T2DM and iRBD (rg=0.306, P=0.029). UVMR analysis indicates that both T2DM (Odds Ratio [95% Confidence Interval] = 1.19 [1.03, 1.37], P = 0.017) and high blood glucose levels (1.55 [1.04, 2.30], P = 0.032) are risk factors for iRBD. Even after adjusting for confounders in MVMR, the association between T2DM and iRBD remains robust. Finally, results from network MR analysis suggest that T2DM may indirectly promote the development of iRBD by reducing levels of Stromal Cell-Derived Factor 2 in circulation and by increasing BAFF-receptor expression in IgD- CD38- B cells.

Conclusions: T2DM may promote the onset of iRBD by influencing immune-inflammatory responses. Our findings provide valuable insights and directions for understanding the pathogenesis of iRBD, identifying high-risk groups, and discovering new therapeutic targets.

References

Sun Y, Guo C, Yuan L, Li W, Wang Z, Yue F . Cynomolgus Monkeys With Spontaneous Type-2-Diabetes-Mellitus-Like Pathology Develop Alpha-Synuclein Alterations Reminiscent of Prodromal Parkinson's Disease and Related Diseases. Front Neurosci. 2020; 14:63. PMC: 7019001. DOI: 10.3389/fnins.2020.00063. View

Xue H, Shen X, Pan W . Constrained maximum likelihood-based Mendelian randomization robust to both correlated and uncorrelated pleiotropic effects. Am J Hum Genet. 2021; 108(7):1251-1269. PMC: 8322939. DOI: 10.1016/j.ajhg.2021.05.014. View

Gong W, Martin T, Sanders A, Jiang A, Sun P, Jiang W . Location, function and role of stromal cell‑derived factors and possible implications in cancer (Review). Int J Mol Med. 2021; 47(2):435-443. PMC: 7797432. DOI: 10.3892/ijmm.2020.4811. View

Li Y, He X, Li Q, Lai H, Zhang H, Hu Z . EV-origin: Enumerating the tissue-cellular origin of circulating extracellular vesicles using exLR profile. Comput Struct Biotechnol J. 2020; 18:2851-2859. PMC: 7588739. DOI: 10.1016/j.csbj.2020.10.002. View

Burgess S, Bowden J, Fall T, Ingelsson E, Thompson S . Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants. Epidemiology. 2016; 28(1):30-42. PMC: 5133381. DOI: 10.1097/EDE.0000000000000559. View

Hickman S, Izzy S, Sen P, Morsett L, El Khoury J . Microglia in neurodegeneration. Nat Neurosci. 2018; 21(10):1359-1369. PMC: 6817969. DOI: 10.1038/s41593-018-0242-x. View

Lv Y, Yuan L, Sun Y, Dou H, Su J, Hou Z . Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson's disease mouse model. Transl Neurodegener. 2022; 11(1):14. PMC: 8900445. DOI: 10.1186/s40035-022-00288-z. View

Gazal S, Finucane H, Furlotte N, Loh P, Palamara P, Liu X . Linkage disequilibrium-dependent architecture of human complex traits shows action of negative selection. Nat Genet. 2017; 49(10):1421-1427. PMC: 6133304. DOI: 10.1038/ng.3954. View

Zheng J, Erzurumluoglu A, Elsworth B, Kemp J, Howe L, Haycock P . LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis. Bioinformatics. 2016; 33(2):272-279. PMC: 5542030. DOI: 10.1093/bioinformatics/btw613. View

10.

Postuma R, Gagnon J, Bertrand J, Genier Marchand D, Montplaisir J . Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials. Neurology. 2015; 84(11):1104-13. PMC: 4371408. DOI: 10.1212/WNL.0000000000001364. View

11.

Thundyil J, Lim K . DAMPs and neurodegeneration. Ageing Res Rev. 2014; 24(Pt A):17-28. DOI: 10.1016/j.arr.2014.11.003. View

12.

Horvath I, Wittung-Stafshede P . Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease. Proc Natl Acad Sci U S A. 2016; 113(44):12473-12477. PMC: 5098634. DOI: 10.1073/pnas.1610371113. View

13.

Xue A, Wu Y, Zhu Z, Zhang F, Kemper K, Zheng Z . Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun. 2018; 9(1):2941. PMC: 6063971. DOI: 10.1038/s41467-018-04951-w. View

14.

Bowden J, Davey Smith G, Haycock P, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016; 40(4):304-14. PMC: 4849733. DOI: 10.1002/gepi.21965. View

15.

Jiang M, Yan W, Zhang Y, Lu Z, Lu T, Zhang D . Phosphodiesterase and psychiatric disorders: a two-sample Mendelian randomization study. J Transl Med. 2023; 21(1):560. PMC: 10441701. DOI: 10.1186/s12967-023-04368-0. View

16.

Li Y, Yang Y, Zhao A, Luo N, Niu M, Kang W . Parkinson's disease peripheral immune biomarker profile: a multicentre, cross-sectional and longitudinal study. J Neuroinflammation. 2022; 19(1):116. PMC: 9131564. DOI: 10.1186/s12974-022-02481-3. View

17.

Wen L, Duffy A . Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes. J Nutr. 2017; 147(7):1468S-1475S. PMC: 5483960. DOI: 10.3945/jn.116.240754. View

18.

Yue X, Li H, Yan H, Zhang P, Chang L, Li T . Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies. Medicine (Baltimore). 2016; 95(18):e3549. PMC: 4863785. DOI: 10.1097/MD.0000000000003549. View

19.

Frauscher B, Jennum P, Ju Y, Postuma R, Arnulf I, Cochen De Cock V . Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study. Neurology. 2014; 82(12):1076-9. PMC: 3962997. DOI: 10.1212/WNL.0000000000000247. View

20.

Martinez-Valbuena I, Amat-Villegas I, Valenti-Azcarate R, Del Mar Carmona-Abellan M, Marcilla I, Tunon M . Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies. Acta Neuropathol. 2018; 135(6):877-886. DOI: 10.1007/s00401-018-1832-0. View